Bonomarlot
Khavinson bone-marrow bioregulator
Bonomarlot is a Khavinson-school peptide bioregulator complex (catalogued as A-20) originally developed from bone-marrow-tissue extracts in Russian gerontology research; unlike the single-sequence Khavinson tetrapeptides, Bonomarlot is a fractionated peptide complex rather than a defined sequence. It has been studied in animal and cell-culture models for haematopoietic-tissue parameters and bone-marrow ageing, alongside other organ-targeted Khavinson preparations such as Cardiogen, Vesugen, and Livagen. Sold by a small subset of research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.
Also known as: A-20, Bone marrow bioregulator
Cost-per-dose recalculates as you adjust the calculator above.
Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.